Compared to the risks of untreated obesity, the potential side effects of GLP-1 weight loss medications are usually minimal and manageable
More research is needed to further elucidate the effect of PG on gut health
Recalls & Warnings February 28, 2017 Seller of Tea Supplements Warned for Manufacturing Violations On February 3, 2017, the FDA issued a warning letter to Kumato Labs, following a facility inspection which found the company's products, including CHO WA Tea, COMOXIN IBS Formula and NEMURI Sleep Formula to be adulterated because they were prepared, packed, or held under
Pre-dosed at 1500mcg per 3ml, this formulation ensures easy handling, accurate measurement, and minimized preparation time for researchers